Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 87170100 |
Registration Number | 5742390 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Joe McKinney Muncy |
Attorney Docket Number | 5900/0500TUS |
Law Office Assigned | L30 |
Employee Name | KUNG, KAELIE ELIZABETH |
2016-09-13 | Application Filed |
2017-09-12 | Published for Opposition |
2018-11-02 | Status: Live/Pending |
2019-01-07 | Location: PETITIONS OFFICE |
2019-01-07 | Transaction Date |
2019-02-19 | Published for Opposition |
2019-05-07 | Trademark Registered |
Owner: | ![]() |
Address | 11F. -1, No. 3 Yuanqu St., Nangang District Taipei City 11503 TW |
Legal Entity Type | Corporation |
Legal Entity State | TW |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0421 | Biochemical research and development; biomedical research services; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; chemical, biochemical, biological and bacteriological research and analysis; development of pharmaceutical preparations and medicines; medical and scientific research, namely, conducting clinical trials for others; medical research services relating to diagnostics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; product development in the field of biopharmaceutical; pharmaceutical research services; pharmaceutical drug development services; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; technical research in the field of drug delivery systems; research and development of new products for medicinal and nutritional use for others |
GS0421 | Biochemical research and development; biomedical research services; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; chemical, biochemical, biological and bacteriological research and analysis; development of pharmaceutical preparations and medicines; medical and scientific research, namely, conducting clinical trials for others; medical research services relating to diagnostics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; product development in the field of biopharmaceutical; pharmaceutical research services; pharmaceutical drug development services; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; technical research in the field of drug delivery systems; research and development of new products for medicinal and nutritional use for others |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2016-09-16 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2016-09-17 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2016-12-19 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2016-12-24 | 4 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2016-12-24 | 5 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2016-12-24 | 6 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-06-23 | 7 TROA I:Incoming Correspondence |
ASSIGNED TO LIE | 2017-07-27 | 8 ALIE A:Allowance for Publication |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-07-31 | 9 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-07-31 | 10 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-08-04 | 11 CNSA P: |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-08-23 | 12 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2017-09-12 | 13 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-09-12 | 14 NPUB E:E-Mail |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2017-11-07 | 15 NOAM E:E-Mail |
TEAS EXTENSION RECEIVED | 2018-05-07 | 16 EEXT I:Incoming Correspondence |
EXTENSION 1 FILED | 2018-05-07 | 17 EXT1 S: |
EXTENSION 1 GRANTED | 2018-05-07 | 18 EX1G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-05-09 | 19 EXRA E:E-Mail |
TEAS PETITION TO DIRECTOR RECEIVED | 2018-11-02 | 20 TPDR I:Incoming Correspondence |
TEAS EXTENSION RECEIVED | 2018-11-02 | 21 EEXT I:Incoming Correspondence |
EXTENSION 2 FILED | 2018-11-02 | 22 EXT2 S: |
EXTENSION 2 GRANTED | 2018-11-02 | 23 EX2G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-11-06 | 24 EXRA E:E-Mail |
ASSIGNED TO PETITION STAFF | 2018-12-12 | 25 APET A:Allowance for Publication |
PETITION INQUIRY LETTER MAILED | 2018-12-14 | 26 PILM I:Incoming Correspondence |
TEAS RESPONSE TO PETITION TO DIRECTOR INQUIRY | 2018-12-28 | 27 ERTI I:Incoming Correspondence |
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED | 2019-01-07 | 28 PCBG O:Outgoing Correspondence |
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED | 2019-01-07 | 29 ATRQ I:Incoming Correspondence |
NOTICE OF ALLOWANCE CANCELLED | 2019-01-16 | 30 IUCN S: |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-01-30 | 31 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2019-02-19 | 32 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-02-19 | 33 NPUB E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2019-05-07 | 34 R.PR A:Allowance for Publication |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-12-23 | 35 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-12-23 | 36 ARAA I:Incoming Correspondence |
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2022-12-23 | 37 ECDR I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-12-23 | 38 TCCA I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-12-28 | 39 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-12-28 | 40 ARAA I:Incoming Correspondence |
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2022-12-28 | 41 ECDR I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-12-28 | 42 TCCA I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-12-28 | 43 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-12-28 | 44 ARAA I:Incoming Correspondence |
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2022-12-28 | 45 ECDR I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-12-28 | 46 TCCA I:Incoming Correspondence |
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2024-05-07 | 47 REM1 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.